Press-release for stocks related to pharm-country for amrn

Prices are updated after-hours

| -6.16% | O: 3.03% H: 8.82% C: 3.92%
vazkepa europe update

Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel's Ministry of Health
Published: 2023-04-04 (Crawled : 14:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -37.65% | O: -0.67% H: 1.35% C: -3.38%
vazkepa health approved

Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2022-12-14 (Crawled : 19:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -24.47% | O: -1.63% H: 7.44% C: 5.79%
conference

Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
Published: 2022-12-07 (Crawled : 15:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -21.93% | O: 0.84% H: 3.33% C: -2.5%
vazkepa approval switzerland

Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference
Published: 2022-08-30 (Crawled : 13:20) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -25.68% | O: 0.0% H: 2.07% C: -3.2%
global conference

NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales
Published: 2022-07-13 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -33.64% | O: 0.0% H: 2.85% C: 0.71%
vazkepa

Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-04 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -65.97% | O: -32.23% H: 3.24% C: -15.68%
results

Amarin to Report Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -72.68% | O: 0.59% H: 4.97% C: 4.68%
financial results conference report results

| -77.93% | O: -0.72% H: 0.0% C: -0.71%
heart test vascepa research

| -83.43% | O: -3.48% H: 0.46% C: -2.22%
risk cardiovascular test vascepa research cardio

Amarin Announces CEO Succession Plan
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -84.33% | O: 0.08% H: 0.0% C: -1.6%
ceo leo

| -84.67% | O: 1.49% H: 2.28% C: -0.33%
risk cardiovascular vascepa cardio

Amarin to Present at Two Upcoming Investor Conferences - Feb 18, 2021
Published: 2021-02-18 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K

| -88.09% | O: -0.77% H: 0.55% C: -2.45%

Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 11:46) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K